litlas
Log inCreate account

Robert H. Pierce

Active 1998–2024

70
Papers
20,459
Citations
54
h-index
68
i10-index

Citations

Citations per year for Robert H. Pierce1993: 1 citations1995: 1 citations1996: 1 citations1999: 1 citations2000: 7 citations2001: 11 citations2002: 17 citations2003: 23 citations2004: 23 citations2005: 22 citations2006: 33 citations2007: 30 citations2008: 36 citations2009: 57 citations2010: 83 citations2011: 83 citations2012: 81 citations2013: 116 citations2014: 113 citations2015: 231 citations2016: 330 citations2017: 392 citations2018: 450 citations2019: 1,031 citations2020: 1,404 citations2021: 1,408 citations2022: 1,153 citations2023: 802 citations2024: 1,048 citations2025: 520 citations2026: 21 citations1994: no citations, so this year is not shown1997–1998: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,788 citing papers, 27.4% of this breakdownChina: 2,124 citing papers, 15.3% of this breakdownUnited Kingdom: 733 citing papers, 5.3% of this breakdownGermany: 730 citing papers, 5.3% of this breakdownFrance: 582 citing papers, 4.2% of this breakdownItaly: 574 citing papers, 4.1% of this breakdownJapan: 463 citing papers, 3.3% of this breakdownNetherlands: 429 citing papers, 3.1% of this breakdownAustralia: 422 citing papers, 3.1% of this breakdownCanada: 382 citing papers, 2.8% of this breakdownSpain: 350 citing papers, 2.5% of this breakdownSwitzerland: 349 citing papers, 2.5% of this breakdown
0%27.4%Other 21.1%

Institutions

Fields

  • Medicine62.1%
  • Immunology and Microbiology19.3%
  • Biochemistry, Genetics and Molecular Biology13.5%
  • Engineering1.8%
  • Pharmacology, Toxicology and Pharmaceutics0.9%
  • Computer Science0.6%
  • Other1.8%

Topics

  • Cancer Immunotherapy and Biomarkers15.9%
  • Immunotherapy and Immune Responses9.2%
  • CAR-T cell therapy research7.2%
  • Immune Cell Function and Interaction6.1%
  • Immune cells in cancer3.8%
  • T-cell and B-cell Immunology1.9%
  • Other55.9%

Coauthors

All papers

Open in search
  1. PD-1 blockade induces responses by inhibiting adaptive immune resistance

    Authors: Paul C. Tumeh, Christina L. Harview, Jennifer H. Yearley, I. Peter Shintaku, Emma Taylor, Lídia Robert, Bartosz Chmielowski, Marko Spasić, Gina Henry, Voicu Ciobanu, Alisha N. West, Manuel Carmona, Christine Kivork, Elizabeth Seja, Grace Cherry, Antonio Gutiérrez, Tristan Grogan, Christine Mateus, Gorana Tomasic, John A. Glaspy, Ryan Emerson, Harlan Robins, Robert H. Pierce, David Elashoff, Caroline Robert, Antoni Ribas - Nature 2014 cited by 6,699

  2. Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12

    Authors: Christopher Garris, Sean P. Arlauckas, Rainer H. Köhler, Marcel P. Trefny, Seth B. Garren, Cécile Piot, Camilla Engblom, Christina Pfirschke, Marie Siwicki, Jeremy Gungabeesoon, Gordon J. Freeman, Sarah Warren, SuFey Ong, Erica Browning, Chris Twitty, Robert H. Pierce, Mai H. Le, Alain P. Algazi, Adil Daud, Sara I. Pai, Alfred Zippelius, Ralph Weissleder, Mikaël J. Pittet - Immunity 2018 cited by 937

  3. Immunogenic Chemotherapy Enhances Recruitment of CAR-T Cells to Lung Tumors and Improves Antitumor Efficacy when Combined with Checkpoint Blockade

    Authors: Shivani Srivastava, Scott N. Furlan, Carla A. Jaeger-Ruckstuhl, Megha Sarvothama, Carolina Berger, Kimberly S. Smythe, Sarah M. Garrison, Jennifer M. Specht, Sylvia M. Lee, Robert A. Amezquita, Valentin Voillet, Vishaka Muhunthan, Sushma Yechan-Gunja, Smitha P.S. Pillai, Christoph Rader, A. McGarry Houghton, Robert H. Pierce, Raphaël Gottardo, David G. Maloney, Stanley R. Riddell - Cancer Cell 2020 cited by 334

  4. Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer

    Authors: Julia Tchou, Yangbing Zhao, Bruce L. Levine, Paul J. Zhang, Megan M. Davis, J. Joseph Melenhorst, Irina Kulikovskaya, Andrea Brennan, Xiaojun Liu, Simon F. Lacey, Avery D. Posey, Austin D. Williams, Alycia So, José R. Conejo-García, Gabriela Plesa, Regina M. Young, Shannon E. McGettigan, Jean S. Campbell, Robert H. Pierce, Jennifer M. Matro, Angela DeMichele, Amy S. Clark, Laurence J.N. Cooper, Lynn M. Schuchter, Robert H. Vonderheide, Carl H. June - Cancer Immunology Research 2017 cited by 443

  5. Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

    Authors: Shona Hendry, Roberto Salgado, Thomas Gevaert, Prudence A. Russell, Tom John, Bibhusal Thapa, Michael Christie, Koen Van de Vijver, Mónica V. Estrada, Paula I. González-Ericsson, Melinda Sanders, Benjamin Solomon, Cinzia Solinas, Gert G. G. M. Van den Eynden, Yves Allory, Matthias Preusser, Johannes A. Hainfellner, Giancarlo Pruneri, Andrea Vingiani, Sandra Demaria, Fraser Symmans, Paolo Nucíforo, Laura Comerma, E. Aubrey Thompson, Sunil R. Lakhani, Seong-Rim Kim, Stuart J. Schnitt, Cécile Colpaert, Christos Sotiriou, Stefan Scherer, Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 cited by 799

  6. Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC

    Authors: Paul C. Tumeh, Matthew D. Hellmann, Omid Hamid, Katy K. Tsai, Kimberly Loo, Matthew A. Gubens, Michael D. Rosenblum, Christina L. Harview, Janis M. Taube, Nathan Handley, Neharika Khurana, Adi Nosrati, Matthew F. Krummel, D. Andrew Tucker, Eduardo V. Sosa, Phillip J. Sanchez, Nooriel Banayan, Juan C. Osorio, Thi Dan Linh Nguyen‐Kim, Jeremy Chang, I. Peter Shintaku, Peter D. Boasberg, Emma Taylor, Pamela N. Münster, Alain P. Algazi, Bartosz Chmielowski, Reinhard Dummer, Tristan Grogan, David Elashoff, Jimmy J. Hwang, Simone M. Goldinger, Edward B. Garon, Robert H. Pierce, Adil Daud - Cancer Immunology Research 2017 cited by 565

  7. Logic-Gated ROR1 Chimeric Antigen Receptor Expression Rescues T Cell-Mediated Toxicity to Normal Tissues and Enables Selective Tumor Targeting

    Authors: Shivani Srivastava, Alexander I. Salter, Denny Liggitt, Sushma Yechan-Gunja, Megha Sarvothama, Kirsten Cooper, Kimberly S. Smythe, Jarrod A. Dudakov, Robert H. Pierce, Christoph Rader, Stanley R. Riddell - Cancer Cell 2019 cited by 325

  8. Phase I Study of Pembrolizumab (MK-3475; Anti–PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors

    Authors: Amita Patnaik, Soonmo Peter Kang, Drew Rasco, Kyriakos P. Papadopoulos, Jeroen Elassaiss‐Schaap, Muralidhar Beeram, Ronald Drengler, Cong Chen, Lon Smith, Guillermo Espino, Kevin Gergich, Liliana Delgado, Adil Daud, Jill A. Lindia, Xiaoyun Li, Robert H. Pierce, Jennifer H. Yearley, Dianna Wu, Omar Laterza, M. Lehnert, Robert Iannone, Anthony W. Tolcher - Clinical Cancer Research 2015 cited by 794

  9. Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research

    Authors: Shona Hendry, Roberto Salgado, Thomas Gevaert, Prudence A. Russell, Tom John, Bibhusal Thapa, Michael Christie, Koen Van de Vijver, Mónica V. Estrada, Paula I. González-Ericsson, Melinda E. Sanders, Benjamin Solomon, Cinzia Solinas, Gert G. G. M. Van den Eynden, Yves Allory, Matthias Preusser, Johannes A. Hainfellner, Giancarlo Pruneri, Andrea Vingiani, Sandra Demaria, Fraser Symmans, Paolo Nucíforo, Laura Comerma, E. Aubrey Thompson, Sunil R. Lakhani, Seong-Rim Kim, Stuart J. Schnitt, Cécile Colpaert, Christos Sotiriou, Stefan Scherer, Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane B. Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André L. Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 cited by 720

  10. IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells

    Authors: Jonathan Sherlock, Barbara Joyce-Shaikh, Scott Turner, Cheng‐Chi Chao, Manjiri Sathe, Jeff Grein, Daniel M. Gorman, Edward P. Bowman, Terrill K. McClanahan, Jennifer H. Yearley, Gérard Eberl, Christopher D. Buckley, Robert A. Kastelein, Robert H. Pierce, Drake LaFace, Daniel J Cua - Nature Medicine 2012 cited by 1,041

  11. Mobilization of CD8+ T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer

    Authors: Yongwoo David Seo, Xiuyun Jiang, Kevin M. Sullivan, Florencia G. Jalikis, Kimberly S. Smythe, Arezou Abbasi, Marissa Vignali, James O. Park, Sara K. Daniel, Seth M. Pollack, Teresa S. Kim, Raymond S. Yeung, Ian Nicholas Crispe, Robert H. Pierce, Harlan Robins, Venu G. Pillarisetty - Clinical Cancer Research 2019 cited by 227

  12. Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA

    Authors: Kelly G. Paulson, Valentin Voillet, Megan S. McAfee, Daniel Hunter, Felecia Wagener, Maurizio Perdicchio, William J. Valente, Samson Koelle, Candice D. Church, Natalie Vandeven, Hannah Thomas, Aric Colunga, Jayasri G. Iyer, Cassian Yee, Rima M. Kulikauskas, David M. Koelle, Robert H. Pierce, Jason H. Bielas, Philip D. Greenberg, Shailender Bhatia, Raphaël Gottardo, Paul Nghiem, Aude G. Chapuis - Nature Communications 2018 cited by 287

  13. Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC

    Authors: Julia Kargl, Xiaodong Zhu, Huajia Zhang, Grace Yang, Travis J. Friesen, Melissa Shipley, Dean Y. Maeda, John A. Zebala, Jill McKay-Fleisch, Gavin Meredith, Afshin Mashadi-Hossein, Christina S. Baik, Robert H. Pierce, Mary W. Redman, Jeffrey C. Thompson, Steven Μ. Albelda, Hamid Bolouri, A. McGarry Houghton - JCI Insight 2019 cited by 192

  14. Tumor immune profiling predicts response to anti–PD-1 therapy in human melanoma

    Authors: Adil Daud, Kimberly Loo, Mariela Pauli, Robert Sanchez Rodriguez, Priscila Muñoz Sandoval, Keyon Taravati, Katy K. Tsai, Adi Nosrati, Lorenzo Nardo, Michael Alvarado, Alain P. Algazi, Miguel Hernandez Pampaloni, Iryna Lobach, Jimmy J. Hwang, Robert H. Pierce, Iris K. Gratz, Matthew F. Krummel, Michael D. Rosenblum - Journal of Clinical Investigation 2016 cited by 527

  15. The Liver–Immunity Nexus and Cancer Immunotherapy

    Authors: James C. Lee, Michael D. Green, Laura A. Huppert, Christine Chow, Robert H. Pierce, Adil I. Daud - Clinical Cancer Research 2021 cited by 115

  16. Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma

    Authors: Alain P. Algazi, Chris Twitty, Katy K. Tsai, Mai H. Le, Robert H. Pierce, Erica Browning, Reneta Hermiz, David A. Canton, Donna Bannavong, Arielle Oglesby, Murray Francisco, Lawrence Fong, Mikaël J. Pittet, Sean P. Arlauckas, Christopher Garris, Lauren P. Levine, Carlos Bifulco, Carmen Ballesteros‐Merino, Shailender Bhatia, Sharron Gargosky, Robert H.I. Andtbacka, Bernard A. Fox, Michael D. Rosenblum, Adil Daud - Clinical Cancer Research 2020 cited by 146

  17. Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study

    Authors: Michael S. Khodadoust, Alain H. Rook, Pierluigi Porcu, Francine Foss, Alison J. Moskowitz, Andrei R. Shustov, Satish Shanbhag, Lubomir Sokol, Steven P. Fling, Nirasha Ramchurren, Robert H. Pierce, Asa K. Davis, Richard Shine, Shufeng Li, Sophia Yui Kau Fong, Jinah Kim, Yi Yang, Wendy M. Blumenschein, Jennifer H. Yearley, Biswajit Das, Rajesh Patidar, Vivekananda Datta, Erin Cantu, Justine N. McCutcheon, Chris Karlovich, P. Mickey Williams, Priyanka B. Subrahmanyam, Holden T. Maecker, Sarah McCue Horwitz, Elad Sharon, Holbrook E. Kohrt, Martin A. Cheever, Youn H. Kim - Journal of Clinical Oncology 2019 cited by 229

  18. Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial

    Authors: Shihong Zhang, Karan Kohli, Graeme Black, Yao Lu, Sydney M. Spadinger, Qianchuan He, Venu G. Pillarisetty, Lee D. Cranmer, Brian A. Van Tine, Cassian Yee, Robert H. Pierce, Stanley R. Riddell, Robin L. Jones, Seth M. Pollack - Cancer Immunology Research 2019 cited by 163

  19. Intratumoral delivery of tavokinogene telseplasmid yields systemic immune responses in metastatic melanoma patients

    Authors: Alain P. Algazi, Shailender Bhatia, Sanjiv S. Agarwala, M. Molina, Karl D. Lewis, Mark B. Faries, Lawrence Fong, Lauren P. Levine, Mauricio Borrero Franco, Ariel Oglesby, Carmen Ballesteros‐Merino, Carlo Bifulco, Bernard A. Fox, Donna Bannavong, Reneta Talia, Erica Browning, Mai H. Le, Robert H. Pierce, Sharron Gargosky, Katy K. Tsai, Chris Twitty, Adil Daud - Annals of Oncology 2020 cited by 135

  20. T-cell Localization, Activation, and Clonal Expansion in Human Pancreatic Ductal Adenocarcinoma

    Authors: Ingunn M. Stromnes, Ayaka Hulbert, Robert H. Pierce, Philip D. Greenberg, Sunil R. Hingorani - Cancer Immunology Research 2017 cited by 198

  21. Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses

    Authors: Katherine J. Brempelis, Courtney M Cowan, Shannon Kreuser, Kevin P. Labadie, Brooke M Prieskorn, Nicole A. P. Lieberman, Chibawanye Ene, Kara White Moyes, Harrison Chinn, Kole DeGolier, Lisa R Matsumoto, Sara K. Daniel, Jason K. Yokoyama, Amira Davis, Virginia J. Hoglund, Kimberly S. Smythe, Stephanie Balcaitis, Michael C. Jensen, Richard G. Ellenbogen, Jean S. Campbell, Robert H. Pierce, Eric C. Holland, Venu G. Pillarisetty, Courtney A. Crane - Journal for ImmunoTherapy of Cancer 2020 cited by 82

  22. Intratumoral Plasmid IL12 Electroporation Therapy in Patients with Advanced Melanoma Induces Systemic and Intratumoral T-cell Responses

    Authors: Samantha K. Greaney, Alain P. Algazi, Katy K. Tsai, Kathryn T. Takamura, Lawrence R. Chen, Chris Twitty, Li Zhang, Alan Paciorek, Robert H. Pierce, Mai H. Le, Adil Daud, Lawrence Fong - Cancer Immunology Research 2019 cited by 95

  23. Toll-Like Receptor 4 Agonist Injection With Concurrent Radiotherapy in Patients With Metastatic Soft Tissue Sarcoma

    Authors: Yongwoo David Seo, Hailing Lu, Graeme Black, Kimberly S. Smythe, Yuexin Yu, Cynthia L. Hsu, Juliana Ng, Pedro Hermida de Viveiros, Edus H. Warren, Brett A. Schroeder, Ryan B. O’Malley, Lee D. Cranmer, Elizabeth T. Loggers, Michael J. Wagner, Lynn Bonham, Venu G. Pillarisetty, Gabrielle Kane, Peter Berglund, Frank J. Hsu, Xinlei Mi, Borislav A. Alexiev, Robert H. Pierce, Stanley R. Riddell, Robin L. Jones, Jan ter Meulen, Edward Y. Kim, Seth M. Pollack - JAMA Oncology 2023 cited by 27

  24. The Collagen Binding α1β1 Integrin VLA-1 Regulates CD8 T Cell-Mediated Immune Protection against Heterologous Influenza Infection

    Authors: Steven J. Ray, Suzanne N. Franki, Robert H. Pierce, Snezhana Dimitrova, Victor Koteliansky, Andrew Sprague, Peter C. Doherty, Antonin R. de Fougerolles, David J. Topham - Immunity 2004 cited by 315